ArticleActa medica Philippina2026
Philippine Clinical Practice Guidelines for Periodic Health Examination: Screening for Infectious Diseases.
Article in Acta medica Philippina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The persistent burden of communicable diseases, coupled with the risk of asymptomatic transmission, underscores the importance of a structured and evidence-based screening approach in the Philippines. Objective: This CPG provides evidence-based recommendations for the screening of asymptomatic, apparently healthy adolescent and adult Filipinos for infectious diseases and those with high-risk conditions. Methods: We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to CPG development recommended in the Department of Health Manual, including GRADE Adolopment, a systematic process of adapting evidence summaries, and the GRADE Evidence to Decision (EtD) framework. The guideline development process had four general steps: 1) identification of priority research questions; 2) evidence synthesis and analysis; 3) formulation of the recommendations based on the balance of benefit, harm, values, and preferences; and 4) implementation and evaluation. The infectious diseases covered in this CPG are syphilis, chlamydia and gonorrhea, asymptomatic bacteriuria, Hepatitis A, Hepatitis C, HIV, dental infections, COVID-19, latent tuberculosis, and intestinal parasitism. Results: The task force developed 18 recommendations (10 strong recommendations, 8 weak recommendations) on screening asymptomatic, apparently healthy children and adults for infectious diseases. Conclusion: This Philippine Clinical Practice Guideline provides evidence-based recommendations for screening infectious diseases among asymptomatic, apparently healthy adolescent and adult Filipinos and those with high-risk conditions, emphasizing a risk-based rather than universal screening approach. The guideline highlights that targeted screening of high-risk populations for infections such as syphilis, HIV, hepatitis C, chlamydia/gonorrhea, and latent tuberculosis can improve early detection, reduce transmission, and prevent complications, while avoiding unnecessary costs and harms associated with indiscriminate screening. Overall, the recommendations reinforce the critical role of primary care and preventive health strategies in reducing the burden of infectious diseases in the Philippines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.